Concepedia

Yunsheng He

YH

13

Publications

2K

Citations

13

H-Index

1993

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

McGill University

Tris Pharma (United States)

Harvard University

Yunsheng He is an author at Novartis (United States) specializing in medicine, cardiovascular genetics, and natural sciences.

ORCID

Top concepts

Publications per year

1993–2022

13

Publications

13

Epigenetic Modification of the <i>FMR1</i> Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

Sébastien Jacquemont, Aurore Curie, Vincent des Portes et al. · Science Translational Medicine · 2011 · 610 citations

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

Howard Feldman, Steven H. Ferris, Bengt Winblad et al. · The Lancet Neurology · 2007 · 335 citations

, , +12

<i>TET2</i>-Driven Clonal Hematopoiesis and Response to Canakinumab

E. C. Svensson, Aviv Madar, Catarina D. Campbell et al. · JAMA Cardiology · 2022 · 333 citations · Full text

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

Roger Bullock, Jacques Touchon, Howard Bergman et al. · Current Medical Research and Opinion · 2005 · 230 citations

An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets

Brian K. Kay, Nils B. Adey, Yunsheng He et al. · Gene · 1993 · 158 citations

, , +10

Rows per page

1–5 of 13